Betty Jo Salmeron, M.D.
National Institute on Drug Abuse (NIDA)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Betty Jo Salmeron, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:30 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06503159 · Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot StudyNational Institute on Drug Abuse (NIDA) · terminated · Vaping Teens, Healthy Volunteers · principal investigator
- N/ANCT05669716 · Adolescent Vaping Characterization and Parent Views on Adolescent Vaping ProtocolNational Institute on Drug Abuse (NIDA) · terminated · Healthy Volunteers, Vaping Teens · principal investigator
- N/ANCT01365988 · Neutral Correlates of Risk-taking in Adolescents Exposed to Drugs PrenatallyNational Institute on Drug Abuse (NIDA) · completed · Exposure · principal investigator
- N/ANCT01036230 · The Effects of Expectation on Natural and Drug -Induced RewardsNational Institute on Drug Abuse (NIDA) · completed · Drug Abuse · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.